Evidence map›Paper›PMID 12486161›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2002

Effects of 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one on synaptic vesicle cycling at the frog neuromuscular junction.

Silvio O Rizzoli, William J Betz

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 55 citations in OpenAlex.

  1. Lipids and Secretory Vesicle Exocytosis.Advances in neurobiology · 2023
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Spontaneous vesicle recycling in the synaptic bouton.Frontiers in cellular neuroscience · 2014
    Review
  9. The reserve pool of synaptic vesicles acts as a buffer for proteins involved in synaptic vesicle recycling.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
  10. A small pool of vesicles maintains synaptic activity in vivo.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
  11. Article
  12. Article
  13. Endosomal sorting of readily releasable synaptic vesicles.Proceedings of the National Academy of Sciences of the United States of America · 2010
    Article
  14. Synaptic vesicle pools: an update.Frontiers in synaptic neuroscience · 2010
    Article
  15. Article
  16. Article
  17. Calcium signaling pathways mediating synaptic potentiation triggered by amyotrophic lateral sclerosis IgG in motor nerve terminals.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2006
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Silvio O RizzoliDepartment of Physiology and Biophysics, University of Colorado Medical School, Denver, Colorado 80262, USA.
William J Betz
University of Colorado Denver · US

Funding

OPTICAL ANALYSIS OF SYNAPTIC VESICLE RECYCLINGR01NS023466 · NINDS · UNIVERSITY OF COLORADO DENVER · PI BETZ, WILLIAM J · 1986 to 2009
$2.8M
NINDS NIH HHS 5 R01 NS23466NINDS NIH HHS R01 NS023466
6 · The paper itself

Abstract

Inositol phospholipids are thought to play an important regulatory role in synaptic membrane traffic. We investigated the effects of perturbing 3-phosphoinositide metabolism on neurotransmission at the frog neuromuscular junction. We used the reversible phosphoinositide-3 kinase (PI3K) inhibitor 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one [LY294002 (LY)] and we examined its effects by intracellular recording, fluorescence imaging with styryl dyes (FM 1-43 and FM 2-10), calcium imaging, and electron microscopy. LY treatment reversibly inhibited vesicle cycling; electron micrographs indicated a dramatic reduction in the number of vesicles, balanced by the appearance of numerous cisternas. LY wash-off reverted the phenotype; terminals were refilled with vesicles, and they resumed normal FM 1-43 uptake and release. Surprisingly, LY treatment also enhanced the frequency of spontaneous release up to 100-fold in a calcium-independent manner. LY evoked similar effects in normal frog Ringer's solution, Ca-free Ringer's solution, and BAPTA AM-pretreated preparations; imaging of nerve terminals loaded with the calcium-sensitive fluorescent dye fluo-3 showed no significant change in fluorescence intensity during LY treatment. FM 1-43 imaging data suggested that LY evoked the cycling of 70-90% of all vesicles. The LY-induced effect on spontaneous release was reproduced by the casein kinase 2 inhibitor 5,6-dichlorobenzimidazole riboside but not, however, by the PI3K inhibitor wortmannin. Because LY has been shown recently to potently inhibit casein kinase 2 as well as PI3K, we hypothesize that casein kinase 2 inhibition is responsible for the enhancement of spontaneous release, whereas PI3K inhibition induces the block of vesicle cycling.

Indexed as

Phosphoinositide-3 Kinase InhibitorsAction PotentialsAnimalsCalciumCasein Kinase IIChromonesCulture TechniquesDichlororibofuranosylbenzimidazoleDrosophilaElectric StimulationEndocytosisEnzyme InhibitorsExocytosisFluorescent DyesKineticsMorpholines2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-oneCalciumCasein Kinase IIChromonesDichlororibofuranosylbenzimidazoleEnzyme InhibitorsFluorescent DyesFM1 43MorpholinesPhosphoinositide-3 Kinase InhibitorsProtein Serine-Threonine KinasesPyridinium CompoundsQuaternary Ammonium Compounds

Identifiers

PMID12486161
PMCPMC6758452
OpenAlexW2128938498

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.